KFSN Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Rates
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
ABRAXIS BIO (NQ: ABII)
+0.1100 (+0.1481%)
at
74.40 USD
11,722 in Volume
Add to:
My Watchlist
Data as of 01:34 PM EDT Sep 9, 2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Today's Open 74.45
Bid (Size) 74.32 (100)
Ask (Size) 74.46 (400)
Prev. Close 74.29
Today's Range 74.34 - 74.55
52wk Range 25.00 - 76.17
Shares Outstanding 40,465,643
Morningstar Profile
View Full Profile
ABRAXIS BIO
Abraxis BioScience, Inc. is a biotechnology company, which is engaged in the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer treatments for cancer and other critical illnesses.
Healthcare
Biotechnology
Exchange Traded NQ
Market Cap 3.01B
Related Companies HLUKY ACV HLUKF PPDI
Top News
Read More
Natco Challenges Celgene's Revlimid - Analyst Blog   
Sep 06, 2010
Celgene Corporation's complaint alleging patent infringement against Natco Pharma. Read More
category ABII , CELG
from Zacks Investment Research - All Commentary Articles
Insiders Are Buying Exelixis. Should You?   
Aug 27, 2010
Maybe, but not because they're buying. Read More
from Fool.com Headlines
More News
Read More
Generic Threat Hanging Over CELG - Analyst Blog   
Aug 27, 2010
category ABII , CELG
from Zacks Investment Research - All Commentary Articles
Celgene's Revlimid Marches on - Analyst Blog   
Aug 20, 2010
category ABII , CELG
from Zacks Investment Research - All Commentary Articles
Zacks Analyst Blog Highlights: Celgene, Abraxis BioScience, Johnson & Johnson, SuperGen and Biogen Idec
Aug 18, 2010
from Business Wire News Releases
Zacks Analyst Blog Highlights: Celgene, Abraxis BioScience, Johnson & Johnson, SuperGen and Biogen Idec - Press Releases   
Aug 18, 2010
category ABII , JNJ , CELG , and 2 more.
from Zacks Investment Research - All Commentary Articles
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Bots go here